… , RTS, S/AS01 vaccine is not perfect. Hereby, the shortages of RTS, S/AS01 malaria vaccine
… Systems analysis of protective immune responses to RTS, S malaria vaccination in humans[…

… RTS,S Clinical Trials Partnership, Agnandji ST, Lell B, et al. First results of phase 3 trial of
RTS,S/AS01 malaria vaccine … immune responses to RTS, S malaria vaccination in humans[J]. …

… and even eventually eliminate malaria. Al⁃ though there are … satisfactory malaria vaccine,
the success of the RTS, S/AS01 malaria … disease vaccines, and a more perfect malaria vaccine …

… of malaria vaccines. Here, we re⁃ view the current status of malaria vaccines development
… ⁃generation malaria vaccines, so as to provide insights into the successful development of …

… pathogens in order to evaluate the efficacy of candidate preventive or therapeutic drugs.
During the COVID-19 pandemic, the HCT of vaccines has aroused people's attention due to its …

… vaccine for general (rather than emergency) use; the pilot rollout in three African countries of
the world’s first malaria vaccine… new drug to treat Alzheimer’s disease in more than a decade…

… .yoelii PALM gene knockout strain was successfully constructed and monocloned,
providing preparation for the development of live attenuated pre-erythrocyte malaria vaccine. …

… In 2020, two COVID-19 vaccines (… The two vaccines showed high efficiency in combating
COVID-19, which indicates the great advantages of mRNA technology in developing vaccines …

… Efficacy of subcutaneous semaglutide compared to placebo for weight lo ss in obese, non-diabetic
adults:A systematic review&meta-analysis[J]. International Journal of Clinical …